Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Circulation

• Publication date

  2000-05-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.101.19.2277PMID 10811595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans.

  1997cited by this paper
• Epicardial bradykinin B2 receptors elicit a sympathoexcitatory reflex in rats.

  1996cited by this paper
• Chymase-dependent angiotensin II forming systems in humans.

  1996cited by this paper
• Chymase-dependent angiotensin II (Ang II) forming system in humans

  1995cited by this paper
• Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis.

  1994cited by this paper
• The myocardial renin-angiotensin system: existence, importance, and clinical implications.

  1992cited by this paper
• Coronary response to diving in subjects with mild and severe left coronary artery disease.

  1992cited by this paper
• Influence of Angiotensin‐Converting Enzyme Inhibition on Sympathetic Neurotransmission: Possible Roles of Bradykinin and Prostaglandins

  1992cited by this paper
• ACE Inhibition Attenuates Sympathetic Coronary Vasoconstriction in Patients With Coronary Artery Disease

  1992cited by this paper
• Angiotensin I and II Some Early Observations Made at The Cleveland Clinic Foundation and Recent Discoveries Relative to Angiotensin II Formation in Human Heart

  1991cited by this paper
• The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.

  1991cited by this paper
• Angiotensin II-forming pathways in normal and failing human hearts.

  1990cited by this paper
• The effect of ACE inhibition on myocardial energy metabolism.

  1990cited by this paper
• Reflex responses to myocardial ischemia and reperfusion. Role of prostaglandins.

  1989cited by this paper
• Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease.

  1989cited by this paper
• Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs.

  1989cited by this paper
• Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension.

  1989cited by this paper
• Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test.

  1988cited by this paper
• Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy.

  1988cited by this paper
• Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.

  1988cited by this paper
• Implications of local angiotensin production in cardiovascular physiology and pharmacology.

  1987influential reference
• Vascular Angiotensin Pathways: A New Therapeutic Target

  1987cited by this paper
• Effects of the cold pressor test on muscle sympathetic nerve activity in humans.

  1987cited by this paper
• Heart Disease and Rehabilitation

  1986cited by this paper
• Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts.

  1984cited by this paper
• Interaction between sympathetic and renin-angiotensin system.

  1984cited by this paper
• Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

  1980cited by this paper
• Hormone Interactions in the Isolated Rabbit Heart: SYNTHESIS AND CORONARY VASOMOTOR EFFECTS OF PROSTAGLANDINS, ANGIOTENSIN, AND BRADYKININ

  1975cited by this paper
• The effect of intracoronary injection of contrast medium upon coronary blood flow.

  1975cited by this paper
• Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man

  1971cited by this paper
• Vasoconstrictor response to simulated diving in man.

  1968cited by this paper

• Elevated heart rate and cardiovascular risk in hypertension.

  2021cites this paper
• Fractionation and bioassay-guided isolation of antihypertensive components of Senecio serratuloides

  2020cites this paper
• Sympathetic Nervous System and Hypertension

  2017cites this paper
• Current Approaches to Quantifying Tonic and Reflex Autonomic Outflows Controlling Cardiovascular Function in Humans and Experimental Animals

  2015cites this paper
• Metabolic syndrome: a sympathetic disease?

  2015cites this paper
• Mancia and Grassi Autonomic Nervous System and Hypertension

  2014cites this paper
• Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study

  2014cites this paper
• The Autonomic Nervous System and Hypertension

  2014cites this paper
• Do high doses of AT(1)-receptor blockers attenuate central sympathetic outflow in humans with chronic heart failure?

  2013cites this paper
• Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".

  2010cites this paper
• Angiotensin-converting enzyme gene I/D genotype affected metoprolol-induced reduction in 24-hour average heart rate.

  2010cites this paper
• The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?

  2008cites this paper
• Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?

  2007cites this paper
• Renin: at the heart of the mast cell

  2007influential citation
• Intracardiac and Intrarenal Renin-Angiotensin Systems

  2007cites this paper
• Cardiovascular Regulation: Basic Considerations

  2007cites this paper
• Angiotensin–sympathetic system interactions in cardiovascular and metabolic disease

  2006cites this paper
• Angiotensin II and norepinephrine release: interaction and effects on the heart

  2005cites this paper
• Peri-procedural myocardial injury: 2005 update.

  2005cites this paper
• Sympathetic and baroreflex function in hypertension: implications for current and new drugs.

  2004cites this paper
• Cardiorenal Effects of the Renin-Angiotensin-Aldosterone System

  2004cites this paper
• The Renin‐Angiotensin‐Aldosterone System: Cardiorenal Effects and Implications for Renal and Cardiovascular Disease States

  2003cites this paper
• Can the premises of the spasm of resistance vessel concept permit improvement in the treatment and prevention of ischemic heart disease?

  2003cites this paper
• Renin-angiotensin-aldosterone system: Fundamental aspects and clinical implications in renal and cardiovascular disorders

  2003cites this paper
• Cold temperature impairs maximal exercise performance in patients with heart failure: attenuation by acute ACE inhibitor therapy.

  2002cites this paper
• Exogenous Angiotensin II Does Not Facilitate Norepinephrine Release in the Heart

  2002cites this paper
• Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy

  2002cites this paper
• Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis.

  2001cites this paper
• Therapeutic potential of angiotensin II receptor

  2001cites this paper
• Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions.

  2001cites this paper
• Therapeutic potential of angiotensin II receptor antagonists

  2001cites this paper